Health TrialsbyHealthPanel

The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation

ConditionsCardiac ArrestFrailtyRespiratory Arrest
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUmraniye Education and Research Hospital

About this trial

The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

pediatric patients

Disqualifiers

pregnant patients

Trial population

Adult patients with hospitalization and those who are not inpatients (in the outpatient clinic system) requiring Code Blue will be included in the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Edmonton frailty scale calculation

    Other intervention

    The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile

Treatment groups

2 Participants
are divided into 2 treatment groups
Group A: Edmonton frailty scale ≥ 71 intervention
Group B: Edmonton frailty scale below 71 intervention

Trial outcomes

Primary outcomes

1

code blue reason

comorbid disease and dog usage

Time frame
years
2

duration of CPR time

between the time of giving the blue code and the end of CPR

Time frame
hours

Secondary outcomes

1

the airway equipment used

intubation, supraglottic airway devices, tracheostomy, cricothyroidectomy, fiberbronchoscopy

Time frame
days
2

mortality and morbidity

presence and duration of intensive care unit stay

Time frame
mounts

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Umraniye Education and Research Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now